<DOC>
	<DOCNO>NCT00221611</DOCNO>
	<brief_summary>Evaluation effect intrathecal administration Baclofen spasticity cerebral palsy patient , mean standardize internationally accepted scale</brief_summary>
	<brief_title>Intrathecal Administration Baclofen ( ITB ) Cerebral Palsy Patients With Therapy-Resistant Spasticity</brief_title>
	<detailed_description>Evaluation effect intrathecal administration Baclofen spasticity cerebral palsy patient , mean standardize internationally accepted scale</detailed_description>
	<mesh_term>Paralysis</mesh_term>
	<mesh_term>Cerebral Palsy</mesh_term>
	<criteria>CP patient therapyresistent spasticity Patients sufficient body weight relation volume Oral medication fail : insufficient effect many sideeffects The patient family understand objective treatment accept objective Informed Consent Contraindications surgery ( e.g . infection ) Hypersensitivity oral Baclofen</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>25 Years</maximum_age>
	<verification_date>December 2007</verification_date>
</DOC>